CD45RB Glycosylation and Ig Isotype Define Maturation of Functionally Distinct B Cell Subsets in Human Peripheral Blood
| Authors |
|
|---|---|
| Publication date | 2022 |
| Journal | Frontiers in Immunology |
| Article number | 891316 |
| Volume | Issue number | 13 |
| Number of pages | 8 |
| Organisations |
|
| Abstract |
Glycosylation of CD45RB (RB+) has recently been identified to mark antigen-experienced B cells, independent of their CD27 expression. By using a novel combination of markers including CD45RB glycosylation, CD27 and IgM/IgD isotype expression we segregated human peripheral blood B cell subsets and investigated their IGHV repertoire and in vitro functionality. We observed distinct maturation stages for CD27-RB+ cells, defined by differential expression of non-switched Ig isotypes. CD27-RB+ cells, which only express IgM, were more matured in terms of Ig gene mutation levels and function as compared to CD27-RB+ cells that express both IgM and IgD or cells that were CD27-RB-. Moreover, CD27-RB+IgM+ cells already showed remarkable rigidity in IgM isotype commitment, different from CD27-RB+IgMD+ and CD27-RB- cells that still demonstrated great plasticity in B cell fate decision. Thus, glycosylation of CD45RB is indicative for antigen-primed B cells, which are, dependent on the Ig isotype, functionally distinct.
|
| Document type | Article |
| Language | English |
| Published at | https://doi.org/10.3389/fimmu.2022.891316 |
| Downloads |
CD45RB Glycosylation
(Final published version)
|
| Supplementary materials | |
| Permalink to this page | |
